Evidence map›Paper›PMID 24218594›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2013

Site-2 protease substrate specificity and coupling in trans by a PDZ-substrate adapter protein.

Jessica S Schneider, Shilpa P Reddy, Hock Y E, Henry W Evans, Michael S Glickman

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Close Related Drug-Resistance Beijing Isolates ofInternational journal of molecular sciences · 2022
    Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jessica S SchneiderImmunology Program, Sloan-Kettering Institute, New York, NY 10021.
Shilpa P Reddy
Hock Y E
Henry W Evans
Michael S Glickman
Kettering University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Cyclopropane Synthetases and M.tuerculosis VirulenceR01AI053417 · NIAID · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI GLICKMAN, MICHAEL S · 2003 to 2012
$3.9M
IMMUNOLOGY RESEARCH TRAINING PROGRAMT32AI007621 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI CESARMAN, ETHEL · 1999 to 2014
$3.4M
Molecular Analysis of the Rip1 Virulence Pathway of M. tuberculosisR01AI080628 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI GLICKMAN, MICHAEL S · 2009 to 2010
$942k
NCI NIH HHS P30 CA008748NIAID NIH HHS AI53417NIAID NIH HHS R01 AI053417NIAID NIH HHS R01 AI080628NIAID NIH HHS T32 AI007621
6 · The paper itself

Abstract

Site-2 proteases (S2Ps) are intramembrane metalloproteases that cleave transmembrane substrates in all domains of life. Many S2Ps, including human S2P and Mycobacterium tuberculosis Rip1, have multiple substrates in vivo, which are often transcriptional regulators. However, S2Ps will also cleave transmembrane sequences of nonsubstrate proteins, suggesting additional specificity determinants. Many S2Ps also contain a PDZ domain, the function of which is poorly understood. Here, we identify an M. tuberculosis protein, PDZ-interacting protease regulator 1 (Ppr1), which bridges between the Rip1 PDZ domain and anti-sigma factor M (Anti-SigM), a Rip1 substrate, but not Anti-SigK or Anti-SigL, also Rip1 substrates. In vivo analyses of Ppr1 function indicate that it prevents nonspecific activation of the Rip1 pathway while coupling Rip1 cleavage of Anti-SigM, but not Anti-SigL, to site-1 proteolysis. Our results support a model of S2P substrate specificity in which a substrate-specific adapter protein tethers the S2P to its substrate while holding the protease inactive through its PDZ domain.

Indexed as

Models, BiologicalAnimalsBacterial ProteinsMetalloproteasesMiceMycobacterium tuberculosisPDZ DomainsReal-Time Polymerase Chain ReactionSigma FactorSignal TransductionSubstrate SpecificityTwo-Hybrid System TechniquesYeastsBacterial ProteinsMetalloproteasesSigma Factorintramembrane proteolysisSigma factorsignal transductionTuberculosis

Identifiers

PMID24218594
PMCPMC3845159
OpenAlexW2144236818

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.